Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Limantrafin + NSAI in Advanced Breast Cancer
NCT04714619Phase 2Terminated
- Sponsor
- MEDSIR
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of limantrafin in breast cancer, sponsored by MEDSIR. Started May 2021; status: terminated.
02
Drugs
limantrafin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04714619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714619.